The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy

The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy

The treatment outcome of breast cancer is closely related to estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression. Triple-negative breast cancer (TNBC) lacking ER, PR, and HER2 expression has limited treatment options and a poor prognosis...

Full description

Bibliographic Details
Main Authors:	Ruonan Li, Lili Cao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Immunology
Subjects:	triple-negative breast cancer (TNBC) tumor-infiltrating lymphocytes (TILs) adoptive cell therapy (ACT) breast cancer solid tumor
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1194020/full

Similar Items

Clinical and radiomics integrated nomogram for preoperative prediction of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer
by: Ling Hu, et al.
Published: (2024-03-01)

Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer
by: Guan-Hua Su, et al.
Published: (2022-10-01)

THE ROLE OF TUMOR-INFILTRATING LYMPHOCYTES IN TRIPLE NEGATIVE BREAST CANCER
by: Anca Zgura, et al.
Published: (2018-09-01)

Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group
by: Mieke R. Van Bockstal, et al.
Published: (2021-09-01)

Tumor‐infiltrating lymphocyte transfusion in a patient with treatment refractory triple negative breast cancer
by: Arielle Jacover, et al.
Published: (2023-12-01)

Tumor-infiltrating lymphocytes in triple negative breast cancer
by: L. M. Zakhartseva, et al.
Published: (2020-12-01)

Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast
by: Hajime Kuroda, et al.
Published: (2021-03-01)

Correlation Between Mammographic Radiomics Features and the Level of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer
by: Hongwei Yu, et al.
Published: (2020-04-01)

Prognostic Factors and Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer
by: Özgecan Dülgar, et al.
Published: (2020-10-01)

Lumpectomy followed by radiation improves survival in HER2 positive and triple‐negative breast cancer with high tumor‐infiltrating lymphocytes compared to mastectomy alone
by: Jason A. Mouabbi, et al.
Published: (2021-07-01)

TUMOR-INFILTRATING LYMPHOCYTES IN TRIPLE NEGATIVE BREAST CANCER: CORRELATIVE ANALYSES OF OWN DATA AND LITERATURE REVIEW
by: Liubov Zakhartseva, et al.
Published: (2019-06-01)

Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer
by: Carlos Alexander Huertas-Caro, et al.
Published: (2022-07-01)

Immunity and cancer: role of tumor-infiltrating lymphocytes in triple-negative breast cancer
by: Ana Tečić-Vuger, et al.
Published: (2021-01-01)

Modeling ex vivo tumor-infiltrating lymphocyte expansion from established solid malignancies
by: Hannah M Knochelmann, et al.
Published: (2021-01-01)

A Computational Tumor-Infiltrating Lymphocyte Assessment Method Comparable with Visual Reporting Guidelines for Triple-Negative Breast Cancer
by: Peng Sun, et al.
Published: (2021-08-01)

Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
by: Guoxuan Gao, et al.
Published: (2020-03-01)

Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
by: Sotiris Loizides, et al.
Published: (2023-01-01)

Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
by: Jesse Lopes da Silva, et al.
Published: (2021-11-01)

Insulin-like growth factor 2 receptor is a key immune-related gene that is correlated with a poor prognosis in patients with triple-negative breast cancer: A bioinformatics analysis
by: Ying Zhong, et al.
Published: (2022-10-01)

Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients
by: Sejdi Lusho, et al.
Published: (2021-07-01)

Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers
by: Miao Ruan, et al.
Published: (2018-08-01)

Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC
by: Luca Campedel, et al.
Published: (2020-09-01)

Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients
by: Pooja M. Vaid, et al.
Published: (2022-11-01)

Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
by: Yueshui Zhao, et al.
Published: (2022-08-01)

LAG-3+ tumor-infiltrating lymphocytes ameliorates overall survival in triple-negative breast cancer patients
by: Guoming Hu, et al.
Published: (2023-01-01)

Syndecan-1 as an immunogene in Triple-negative breast cancer: regulation tumor-infiltrating lymphocyte in the tumor microenviroment and EMT by TGFb1/Smad pathway
by: Ying Zhong, et al.
Published: (2023-04-01)

Why do tumor-infiltrating lymphocytes have variable efficacy in the treatment of solid tumors?
by: Biaoru Li
Published: (2022-10-01)

HER2-low and tumor infiltrating lymphocytes in triple-negative breast cancer: Are they connected?
by: Ximena Baez-Navarro, et al.
Published: (2024-03-01)

Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
by: Mohammad Hossein Kazemi, et al.
Published: (2022-10-01)

Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy
by: Sylvie Giacchetti, et al.
Published: (2022-03-01)

Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy
by: Sharon Yunger, et al.
Published: (2019-12-01)

Prognostic Significance of Lymphocyte Infiltrate Localization in Triple-Negative Breast Cancer
by: Toni Čeprnja, et al.
Published: (2022-06-01)

Expression patterns and prognostic implications of tumor-infiltrating lymphocytes dynamics in early breast cancer patients receiving neoadjuvant therapy: A systematic review and meta-analysis
by: Yajing Zhu, et al.
Published: (2022-11-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01)

Evaluation of triple negative breast cancer with heterogeneous immune infiltration
by: Ángela Quintana, et al.
Published: (2023-05-01)

Prognostic Impact of CD38- and IgκC-Positive Tumor-Infiltrating Plasma Cells in Triple-Negative Breast Cancer
by: Anne-Sophie Heimes, et al.
Published: (2023-10-01)

Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells
by: Roberta Sommaggio, et al.
Published: (2020-01-01)

Relation Between CD8+T Lymphocyte Infiltration and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer
by: KONG Tiandong, et al.
Published: (2021-05-01)

Tumor inflating lymphocytes. Purification, expanding and cytotoxicity analisys on primary tumor cultures
by: G. M. Yusubalieva, et al.
Published: (2020-05-01)

Tumor Infiltrating Lymphocytes across Breast Cancer Subtypes: Current Issues for Biomarker Assessment
by: Carmine Valenza, et al.
Published: (2023-01-01)